Barker, Alex J. https://orcid.org/0000-0002-6283-9157
Berthusen, Alexander
Vigers, Tim
Schafer, Michal
Browne, Lorna P.
Bjornstad, Petter
Funding for this research was provided by:
National Institutes of Health (R01 DK129211, R01 DK132399, R21 DK129720, K23 DK116720, UC2 DK114886)
Article History
Received: 26 July 2022
Revised: 14 November 2022
Accepted: 15 November 2022
First Online: 2 December 2022
Declarations
:
: P.B. reports serving as a consultant for AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, LG Chemistry, Sanofi, Novo Nordisk, and Horizon Pharma. P.B. also serves on the advisory boards and/or steering committees of AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk, and XORTX. The other authors have no relationships relevant to the contents of this paper to disclose.